FDA opens path to approval for Huntington's gene therapy
The US Food and Drug Administration is allowing biotech company uniQure to reapply for the licensing of a gene therapy that could slow the progression of Huntington's disease...
MicroRNAs are small, non-coding RNA molecules that regulate gene expression by suppressing the RNA pathway that translates genes into protein. They act like 'master switches', having the ability to control the activity of multiple genes.
The US Food and Drug Administration is allowing biotech company uniQure to reapply for the licensing of a gene therapy that could slow the progression of Huntington's disease...
Clinical guidelines for Huntington's disease have been brought together for the first time in a single resource to support more consistent care for patients...
A microRNA treatment is the first therapy to show evidence of slowing Huntington's disease progression....
Nobel Prizes have been awarded to scientists for microRNA discovery, protein structure, and artificial neural network research...
Hair growth has been stimulated in young and old mice using microRNA, with the potential for future trials in humans to treat baldness...
For the first time, scientists have demonstrated that a genetic therapy can regenerate heart tissue after heart attack injury in a large mammal...
Human sperm possess a 'memory' of early life trauma that can be transmitted to offspring through changes in microRNA levels, a new study has shown for the first time...
Researchers have slowed the growth of pancreatic cancer by harnessing genome editing to remove key molecules implicated in its spread...
Subscribe for free to what PET does best – informing you of the latest in fertility, genomics and embryo research.